| |
|
|
|
Arcus Biosciences Inc.  
|
|
6.44 -0.36 (-0.05%) |
08-23 16:02 |
|
Open: |
6.75 |
Pre close: |
6.8 |
Target:
|
9.09
|
|
High: |
6.91 |
Low: |
6.36 |
Resistance:
|
7.78
8.70
|
|
Volume: |
120,784 |
Market Cap: |
287M |
Support:
|
6.30
5.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.91
 |
MACD |
MACD(12,26):
|
-0.34 |
|
MA(20): |
7.18 |
Signal(12,26,9): |
-0.33 |
|
MA(100): |
9.10 |
Stochastic Oscillator |
%K(14,3):
|
27.92 |
|
MA(250): |
10.65 |
%D(3): |
34.92 |
|
Average Volume(K) |
3-Month: |
19618
|
52-Week |
High:
|
16.06 |
|
10-Days: |
14693 |
Low: |
6.30 |
|
RSI |
RSI(14):
|
34.66 |
Change(%): |
-52.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.260 |
Return on Equity (ttm) |
-22.3 |
Shares Out. (M) |
44.53 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-13.4 |
Shares Float (M) |
25.28 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.39 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
40.0 |
% Held by Institutions |
50.07 |
|
Forward EPS |
-1.849 |
Gross Profit (p.s.) |
-0.927 |
Shares Short (K) |
2130 |
|
Book Value (p.s.) |
5.070 |
EBITDA (p.s.) |
-1.269 |
P/E |
-5.11 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.59 |
P/S |
1433866112.00 |
|
Operating Margin |
-681.14 |
Levered Free Cash Flow
(M) |
-28.78 |
P/CF |
-6.16 |
|
|
|
|
|
|
